Anika Therapeutics Inc. Selling, General and Administrative (SG&A) Expenses Growth

Selling, General and Administrative (SG&A) Expenses Growth of ANIK for past 10 years: annual, quarterly and twelve month trailing (TTM) including Selling, General and Administrative (SG&A) Expenses Growth growth rates and interactive chart.


Highlights and Quick Summary

  • Selling, General and Administrative (SG&A) Expenses Growth for the quarter ending June 30, 2022 was 18.23% (a 222.65% increase compared to previous quarter)
  • Year-over-year quarterly Selling, General and Administrative (SG&A) Expenses Growth increased by 81.57%
  • Annual Selling, General and Administrative (SG&A) Expenses Growth for 2021 was 34.87% (a -40.91% decrease from previous year)
  • Annual Selling, General and Administrative (SG&A) Expenses Growth for 2020 was 59.01% (a 9417.74% increase from previous year)
  • Annual Selling, General and Administrative (SG&A) Expenses Growth for 2019 was 0.62% (a -98.96% decrease from previous year)
  • Twelve month Selling, General and Administrative (SG&A) Expenses Growth ending June 30, 2022 was 16.59% (a -6.43% decrease compared to previous quarter)
  • Twelve month trailing Selling, General and Administrative (SG&A) Expenses Growth decreased by -19.15% year-over-year
Trailing Selling, General and Administrative (SG&A) Expenses Growth for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
16.59% 17.73% 23.36% 20.52%
Visit stockrow.com/ANIK for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Selling, General and Administrative (SG&A) Expenses Growth of Anika Therapeutics Inc.

Most recent Selling, General and Administrative (SG&A) Expenses Growthof ANIK including historical data for past 10 years.

Interactive Chart of Selling, General and Administrative (SG&A) Expenses Growth of Anika Therapeutics Inc.

Anika Therapeutics Inc. Selling, General and Administrative (SG&A) Expenses Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 18.23% 5.65%
2021 34.61% 10.04% 23.64% 25.94% 34.87%
2020 24.04% 110.94% 93.95% 88.1% 59.01%
2019 99.66% 32.26% 16.91% -52.32% 0.62%
2018 -8.22% 18.18% 29.06% 217.54% 59.41%
2017 21.68% 12.69% 16.85% 26.99% 19.58%
2016 21.34% 29.34% 25.59% 10.68% 21.5%
2015 23.16% -18.19% -12.36% 3.27% -1.65%
2014 53.06% 26.84% 13.68% -11.56% 16.53%
2013 -34.57% -11.47% -17.23% 17.79% -12.17%
2012 -24.68% -23.57% -2.95% -17.13% -17.53%
2011 17.25% 20.56% 3.12%

Business Profile of Anika Therapeutics Inc.

Sector: Healthcare
Industry: Medical Devices